Bruker (BRKR)
(Delayed Data from NSDQ)
$80.59 USD
-1.61 (-1.96%)
Updated Apr 25, 2024 04:00 PM ET
2-Buy of 5 2
C Value C Growth B Momentum C VGM
Income Statements
Fiscal Year end for Bruker Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 2,965 | 2,531 | 2,418 | 1,988 | 2,073 |
Cost Of Goods | 1,451 | 1,225 | 1,208 | 1,048 | 1,077 |
Gross Profit | 1,513 | 1,306 | 1,210 | 940 | 995 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,076 | 873 | 796 | 692 | 694 |
Income After Depreciation & Amortization | 437 | 433 | 413 | 248 | 301 |
Non-Operating Income | 107 | -19 | -20 | -23 | -21 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 544 | 414 | 394 | 226 | 280 |
Income Taxes | 118 | 116 | 113 | 64 | 82 |
Minority Interest | 1 | 2 | 4 | 4 | 1 |
Investment Gains/Losses | 2 | 1 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 429 | 299 | 281 | 161 | 198 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 427 | 297 | 277 | 158 | 197 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 552 | 522 | 502 | 329 | 377 |
Depreciation & Amortization (Cash Flow) | 115 | 89 | 89 | 80 | 76 |
Income After Depreciation & Amortization | 437 | 433 | 413 | 248 | 301 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 147.20 | 149.40 | 152.90 | 154.60 | 156.60 |
Diluted EPS Before Non-Recurring Items | 2.58 | 2.34 | 2.10 | 1.35 | 1.57 |
Diluted Net EPS (GAAP) | 2.90 | 1.99 | 1.81 | 1.02 | 1.26 |
Fiscal Year end for Bruker Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 854.50 | 742.80 | 681.90 | 685.30 |
Cost Of Goods | NA | 424.20 | 360.00 | 341.40 | 325.60 |
Gross Profit | NA | 430.30 | 382.80 | 340.50 | 359.70 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 326.80 | 258.30 | 254.30 | 237.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 103.50 | 124.50 | 86.20 | 122.70 |
Non-Operating Income | NA | -6.70 | -5.30 | -8.70 | -16.10 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | 240.90 | 119.20 | 77.50 | 106.60 |
Income Taxes | NA | 37.10 | 30.80 | 19.90 | 29.90 |
Minority Interest | NA | -0.90 | 0.60 | 0.70 | 0.90 |
Investment Gains/Losses | NA | 0.80 | 0.30 | 0.20 | 0.70 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 204.60 | 88.70 | 57.80 | 77.40 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 205.50 | 88.10 | 57.10 | 76.50 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 146.00 | 147.30 | 147.70 | 147.60 |
Diluted EPS Before Non-Recurring Items | NA | 0.70 | 0.74 | 0.50 | 0.64 |
Diluted Net EPS (GAAP) | NA | 1.39 | 0.60 | 0.39 | 0.52 |